Commentary on Serre et al. : Demonstrating the next era of addiction science
Bryant M. Stone, Johannes Thrul

TL;DR
The paper discusses how new data collection methods are transforming addiction research by enabling deeper insights into substance use and behavioral addictions.
Contribution
It highlights the use of ecological momentary assessments and network analyses as innovative approaches in addiction science.
Findings
Real-time data collection methods like ecological momentary assessments are reshaping addiction research.
Network analyses provide new insights into substance use and behavioral addictions.
Serre et al.'s study exemplifies the potential of these innovative approaches.
Abstract
Innovative real-time data collection methodologies, including ecological momentary assessments, allow researchers to apply cutting-edge analytical tools, such as network analyses—unlocking insights that reshape our understanding of substance use and behavioral addictions. Serre et al.’s study epitomizes these innovative approaches poised to advance addiction research.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMental Health Research Topics · Digital Mental Health Interventions · Health, Environment, Cognitive Aging
Persistent challenges to accurately conceptualizing and effectively treating substance use disorders (SUDs) and behavioral addictions have motivated researchers to adopt increasingly sophisticated methodologies. Among these methods, Ecological Momentary Assessments (EMA) [1–4]—real-time data collected in individuals’ daily lives—combined with cutting-edge network analyses, such as multi-level vector autoregression models and group iterative multiple model estimation (GIMME) [5–7], offer much potential to improve our understanding of substance use and other addictive behaviors. Serre et al.’s [1] recent study exemplifies how these methods may reshape addiction research by capturing and modeling the dynamic, moment-to-moment fluctuations in key variables (e.g., craving and self-efficacy), producing rich and highly precise information on potential treatment targets. Combining EMA as a data collection design choice with network analyses as an analytical choice, this study highlights the value of conceptualizing addictions as a personalized, fluid process requiring individualized medicine—paving the way for the next frontier of addiction research and treatments. We note two key reasons why this study’s design and analytical choice articulate this combination’s potential and impact [8].
Broad applications
Integrating EMA with network analyses enables a deeper investigation into how internal states (e.g., mood or craving) and environmental factors (e.g., distressing events) interact over time to predict substance use and behavioral addiction outcomes [9]. Compared to more traditional analytical approaches, such as mixed models, these network analyses have the advantage that they model the joint influence of all variables in the model and allow for complex time-ordered relationships between variables to emerge [10]. By capturing and analyzing real-time fluctuations in key variables preceding and following cravings, use, and experiences of withdrawal, these methods can provide nuanced insights into relapse patterns. This approach helps to address crucial questions, such as why individuals continue using or return to use substances despite negative consequences and which factors (e.g., social cues, emotional states) trigger or mitigate use and relapse.
The future of understanding and treating addictions
EMA and network analyses have the potential to transform addiction research and treatments by offering real-time tools that capture the unique complexities of substance use and behavioral addictions for each patient [6, 7], and subsequently allow us to address them in treatment. In the study by Serre et al. [1], EMA captured real-time fluctuations in mood, stress and social context, then a multi-level vector autoregression model mapped dynamic contemporaneous, temporal and between-subjects interactions, identifying crucial treatment targets such as craving and self-efficacy. This combined approach revealed how these variables vary within and between individuals [6, 7], emphasizing the need for flexible, personalized interventions that providers may find helpful [8–10]. If we can integrate mHealth technologies [11, 12], these methods can inform individualized interventions at the right moments, allowing clinicians to address the seemingly unpredictable and dynamic triggers of substance use behaviors with unprecedented precision. This degree of personalization far exceeds current intervention strategies in timing and precision and could improve treatment effectiveness, including relapse prevention [13].
OVERCOMING BARRIERS AND EMBRACING INNOVATION
Despite this transformative potential of EMA and network analyses, their adoption thus far has remained limited. Researchers and clinicians may view these methods as overly complex or impractical for routine use in clinical care—currently a valid concern, given the demands of modern medical practice [14]. However, Serre et al. [1] demonstrate that applications of these techniques can yield significant, actionable insights. Their study shows that we can uncover individuals’ unique vulnerabilities and the nuanced variability of their behavioral patterns, the first step to paving the way for the inevitable personalization of addiction research and treatments. The greatest challenge may not lie in the mHealth tools themselves, but in demystifying these methods and highlighting successful cases such as those of Serre et al. (2024) [1] to inspire broader adoption and drive funding for further innovation. Addiction research is uniquely poised to lead this evolution in data collection and analysis. In doing so, we can set a standard for other medical fields, also moving towards dynamic, precise interventions. In other words, the question is no longer whether these tools can make a difference, but whether we are prepared to fully embrace them and take the next critical step.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Serre F, Gauld C, Lambert L, Baillet E, Beltran V, Daulouede J-P, Predictors of substance use during treatment for addiction: a network analysis of ecological momentary assessment data. Addiction. 2024. 10.1111/add.16658 PMC 1163852339210697 · doi ↗ · pubmed ↗
- 2Shiffman S, Stone AA, Hufford MR. Ecological momentary assessment. Ann Rev Clin Psychol. 2008;4:1–32.18509902 10.1146/annurev.clinpsy.3.022806.091415 · doi ↗ · pubmed ↗
- 3Shiffman S. Conceptualizing analyses of ecological momentary assessment data. Nicotine Tob Res. 2013;16:S 76–87.24323571 10.1093/ntr/ntt 195PMC 3977631 · doi ↗ · pubmed ↗
- 4Thrul J, Buhler A, Ferguson SG. An internet-based ecological momentary assessment study relying on participants’ own mobile phones: insights from a study with young adult smokers. Eur Addict Res. 2014;21:1–5.25342514 10.1159/000363231 · doi ↗ · pubmed ↗
- 5Beltz AM, Gates KM. Network mapping with GIMME. Multivar Behav Res. 2017;52:789–804.10.1080/00273171.2017.1373014 PMC 618144929161187 · doi ↗ · pubmed ↗
- 6Gates KM, Molenaar PC. Group search algorithm recovers effective connectivity maps for individuals in homogeneous and heterogeneous samples. Neuroimage. 2012;63:310–9.22732562 10.1016/j.neuroimage.2012.06.026 · doi ↗ · pubmed ↗
- 7Gates KM, Lane ST, Varangis E, Giovanello K, Guskiewicz K. Unsupervised classification during time-series model building. Multivar Behav Res. 2017;52:129–48.10.1080/00273171.2016.1256187 PMC 854984627925768 · doi ↗ · pubmed ↗
- 8Hall M, Lappenbusch LM, Wiegmann E, Rubel JA. To use or not to use: exploring therapists’ experiences with pre-treatment EMA-based personalized feedback in the Thera Net project. Adm Policy Ment Health. 2024. 10.1007/s 10488-023-01333-3PMC 1170398538261117 · doi ↗ · pubmed ↗
